Mancini Anthony sold RVMD

March 25, 2026 · Form 4 insider transaction

Mancini Anthony sold 21,086 shares of Revolution Medicines, Inc. at $95.49 per share, a transaction worth $2.01M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Disposed (sell-side)
Shares
21,086
Price
$95.49
Total value
$2.01M
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 25, 2026
Filing dateMarch 26, 2026
Shares owned after65,836
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on December 24, 2025.; This transaction was executed in multiple trades at prices ranging from $95.00 to $95.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.; Includes 54,400 Restricted Stock Units.

View the original Form 4 on SEC EDGAR